about
Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1/COX-2 and 5-LOX inhibitors.Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs.Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.3D QSAR studies based in silico screening of 4,5,6-triphenyl-1,2,3,4-tetrahydropyrimidine analogs for anti-inflammatory activity.Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs.Design, Synthesis and Anti-breast Cancer activity of Some Novel substituted Isoxazoles as Anti-breast Cancer Agent.Novel 2-(nitrooxy)ethyl 2-(4-(substituted phenyl)-2-((substituted phenyl)amino)thiazol-5-yl)acetate as anti-inflammatory, analgesic and nitric oxide releasing agents: Synthesis and Molecular Docking studies.Ultrasound Mediated One-Pot, Three Component Synthesis, Docking and ADME Prediction of Novel 5-Amino-2-(4-chlorophenyl)-7-Substituted Phenyl-8,8a-dihydro-7H-(1,3,4)thiadiazolo(3,2-α)pyrimidine-6-carbonitrile Derivatives as Anticancer Agents.Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivativesDevelopment of energetic pharmacophore for the designing of 1,2,3,4-tetrahydropyrimidine derivatives as selective cyclooxygenase-2 inhibitorsDesign of selective TACE inhibitors using molecular docking studies: Synthesis and preliminary evaluation of anti-inflammatory and TACE inhibitory activityStructure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD)Pharmaceutical analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its impurities to assist in modern drug discoveryNew amide linked dimeric 1,2,3-triazoles bearing aryloxy scaffolds as a potent antiproliferative agents and EGFR tyrosine kinase phosphorylation inhibitors
P50
Q35677789-FDC2F1A3-419C-4FED-A2F3-B2478C00EB3AQ39958590-4C9361FD-1212-4114-BA43-AC57A4C46129Q42719265-49C057BE-A78A-4E2B-91C0-28B74F51C3F0Q44200147-06E7C305-CAA9-4C94-9443-2381F1752781Q45394429-8F45BC04-F119-4C56-B5A8-7405F9AF4A9DQ47571252-AD86273B-EDF8-4019-A231-903B84C5F6F7Q49990533-3498BC75-75CE-4353-876D-8312354EE33AQ51599865-95ACAA19-05E1-46BB-9C38-032F6D6C1D58Q64891153-6D012CDD-25D6-4BC3-AEB4-B6F045EFB80DQ82677772-9E072FBF-FE7A-4639-816A-CB0EA143F68CQ83178916-05507242-275E-4AE3-BCC0-4A7E9D9F45D1Q86749277-DB3CA109-4D01-46E6-9CF3-48665BD1CDCFQ91544886-BAB9F3E7-8E74-4A4A-931B-2B9DBA437D7EQ91569225-8E8E231D-5ECE-43B0-BA13-4492068B6AD7Q92733438-B8C9AF47-50D4-4361-A6F4-62749217B775
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Deepak K Lokwani
@en
Deepak K Lokwani
@nl
type
label
Deepak K Lokwani
@en
Deepak K Lokwani
@nl
prefLabel
Deepak K Lokwani
@en
Deepak K Lokwani
@nl
P31
P496
0000-0003-2858-678X